We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Search results
From Proteopedia
You searched for Mcinnes,_R.R.
There is no page with the exact title "Mcinnes,_R.R.". The search results for "Mcinnes,_R.R." are displayed below. You can create a page titled Mcinnes,_R.R. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:McInnes A (40 bytes)
1: List of pages with the keyword McInnes A - Category:Mcinnes C (40 bytes)
1: List of pages with the keyword Mcinnes C - Category:Mcinnes, C (41 bytes)
1: List of pages with the keyword Mcinnes, C - Category:Mcinnes, A (41 bytes)
1: List of pages with the keyword Mcinnes, A - Category:McInnes, C (41 bytes)
1: List of pages with the keyword McInnes, C - Category:Mcinnes, R R (43 bytes)
1: List of pages with the keyword Mcinnes, R R - Category:McInnes, S J (43 bytes)
1: List of pages with the keyword McInnes, S J - Category:McInnes SJ (41 bytes)
1: List of pages with the keyword McInnes SJ - Category:Mcinnes RR (41 bytes)
1: List of pages with the keyword Mcinnes RR - Category:McInnes C (40 bytes)
1: List of pages with the keyword McInnes C
Page text matches
- 1ol2 (7,619 bytes)
2: ==Cyclin A binding groove inhibitor H-Arg-Arg-Leu-Asn-(p-F-Phe)-NH2==
3: ...aption='[[1ol2]], [[Resolution|resolution]] 2.60Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OL2 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.6Å</td></tr> - 1ol1 (7,671 bytes)
2: ==Cyclin A binding groove inhibitor H-Cit-Cit-Leu-Ile-(p-F-Phe)-NH2==
3: ...aption='[[1ol1]], [[Resolution|resolution]] 2.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OL1 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.9Å</td></tr> - 2uue (7,808 bytes)
2: ...Iterative Design of Cyclin Binding Groove Inhibitors==
3: ...aption='[[2uue]], [[Resolution|resolution]] 2.06Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2UUE FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.06Å</td></tr> - 1okw (7,675 bytes)
2: ==Cyclin A binding groove inhibitor Ac-Arg-Arg-Leu-Asn-(m-Cl-Phe)-NH2==
3: ...aption='[[1okw]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OKW FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 1urc (7,714 bytes)
2: ==Cyclin A binding groove inhibitor Ace-Arg-Lys-Leu-Phe-Gly==
3: ...aption='[[1urc]], [[Resolution|resolution]] 2.60Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1URC FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.6Å</td></tr> - 2c5n (7,218 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5n]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5N FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - 2c5x (7,245 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5x]], [[Resolution|resolution]] 2.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5X FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.9Å</td></tr> - 2c5v (7,628 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5v]], [[Resolution|resolution]] 2.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5V FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.9Å</td></tr> - 2c5y (7,246 bytes)
2: ...O ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN==
3: ...aption='[[2c5y]], [[Resolution|resolution]] 2.25Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5Y FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.25Å</td></tr> - 2c5o (7,187 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5o]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5O FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - 1aos (2,786 bytes)
2: ==HUMAN ARGININOSUCCINATE LYASE==
3: ...aption='[[1aos]], [[Resolution|resolution]] 4.20Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1AOS FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 4.2Å</td></tr> - Category:McInnes A (40 bytes)
1: List of pages with the keyword McInnes A - 1okv (7,547 bytes)
2: ==Cyclin A binding groove inhibitor H-Arg-Arg-Leu-Ile-Phe-NH2==
3: ...aption='[[1okv]], [[Resolution|resolution]] 2.40Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OKV FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.4Å</td></tr> - 1pw2 (6,759 bytes)
2: ==APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2==
3: ...aption='[[1pw2]], [[Resolution|resolution]] 1.95Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PW2 FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.95Å</td></tr> - 1pxi (7,022 bytes)
2: ...TH THE INHIBITOR 4-(2,5-Dichloro-thiophen-3-yl)-pyrimidin-2-ylamine==
3: ...aption='[[1pxi]], [[Resolution|resolution]] 1.95Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXI FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.95Å</td></tr> - 1pxj (7,027 bytes)
2: ...ITH THE INHIBITOR 4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine==
3: ...aption='[[1pxj]], [[Resolution|resolution]] 2.30Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXJ FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.3Å</td></tr> - 1pxk (7,075 bytes)
2: ...hyl-thiazol-5-yl)pyrimidin-2-yl]-N'-hydroxyiminoformamide==
3: ...aption='[[1pxk]], [[Resolution|resolution]] 2.80Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXK FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.8Å</td></tr> - 1pxl (7,087 bytes)
2: ...-Dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-trifluoromethyl-phenyl)-amine==
3: ...aption='[[1pxl]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXL FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 1pxm (7,483 bytes)
2: ... THE INHIBITOR 3-[4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol==
3: ...aption='[[1pxm]], [[Resolution|resolution]] 2.53Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXM FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.53Å</td></tr> - 1pxn (7,524 bytes)
2: ...ITOR 4-[4-(4-Methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol==
3: ...aption='[[1pxn]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXN FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr>
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
